Journal of orthopaedic trauma
-
We hypothesized that early definitive management (within 24 hours of injury) of mechanically unstable fractures of the pelvis, acetabulum, femur and spine would reduce complications and shorten length of stay. ⋯ Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
-
Assess effectiveness of Injury Severity Score (ISS) in predicting injury severity in combat-related amputations. ⋯ Prognostic Level II. See Instructions for Authors for a complete description of levels of evidence.
-
The purpose of this investigation is to define the location and frequency of tibia pilon fracture lines and impaction injury for the most severe variety (OTA/AO type 43C3). ⋯ There is a consistent fracture pattern underlying the majority of OTA/AO type 43C3 pilon fractures that could be defined as 3 main fragments: anterior, medial, and posterior. These result from a major fracture line extending from the fibular incisura and exiting anterior and posterior to the medial malleolus. The comminution commonly distinguishing pilon fractures occurs from secondary fracture lines through the apex of the plafond and in the anterolateral region. Knowledge of this constant pattern should influence surgical approaches and possibly implant design.
-
Randomized Controlled Trial
Distal locking using an electromagnetic field-guided computer-based real-time system for orthopaedic trauma patients.
To compare the efficacy of distal interlocking during intramedullary nailing using a freehand technique versus an electromagnetic field real-time system (EFRTS). ⋯ Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.
-
Controlled Clinical Trial
The insertion of intramedullary nail locking screws without fluoroscopy: a faster and safer technique.
This study was designed to compare the accuracy, time, and radiation exposure during the insertion of intramedullary nail locking screws using either standard fluoroscopic assistance or an electromagnetic (EM)-based navigational system without fluoroscopy. ⋯ Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.